Related Experiment Video
Updated: Oct 6, 2025
06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
227
Economic Considerations in Access to Transcatheter Aortic Valve Replacement
Kriyana P Reddy1, Peter W Groeneveld1,2,3, Jay Giri1,2,4
1Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center (K.P.R., P.W.G., J.G., A.C.F., A.S.N.), University of Pennsylvania, Philadelphia.
Circulation. Cardiovascular Interventions
|January 13, 2022
Summary
High costs limit access to transcatheter aortic valve replacement (TAVR) for many Americans, particularly minority and disadvantaged groups. This review examines economic barriers to TAVR services in the United States.
Area of Science:
- Cardiovascular medicine
- Health economics
- Health equity
Background:
- Transcatheter aortic valve replacement (TAVR) has transformed aortic stenosis treatment.
- Rising TAVR adoption in the U.S. faces challenges in market expansion.
- Hospitals struggle to balance high TAVR costs with comprehensive care offerings.
Purpose of the Study:
- To analyze hospital-level economic factors influencing TAVR accessibility.
- To investigate the impact of economic considerations on patient access to TAVR.
- To identify disparities in TAVR access based on geography, race, ethnicity, and socioeconomic status.
Main Methods:
- Review of hospital economic considerations for TAVR programs.
- Analysis of factors affecting TAVR program initiation and maintenance.
- Examination of access barriers for diverse patient populations.
Main Results:
- High TAVR costs restrict program establishment and growth in certain markets.
- Economic constraints lead to decreased TAVR access for underserved communities.
- Patients of color and those with socioeconomic disadvantages face greater access limitations.
Conclusions:
- Hospital economic considerations significantly impact TAVR accessibility in the U.S.
- Addressing cost barriers is crucial for improving equitable access to TAVR.
- Policy and strategic initiatives are needed to overcome economic hurdles and promote TAVR equity.
Keywords:
United Statesaortic valveaortic valve stenosishospitalstranscatheter aortic valve replacementMore Related Videos
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
64
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
64
01:26Mitral Stenosis III: Medical Management
37
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
37